Silver Spike Investment Corp. (SSIC)

USD 10.74

(1.27%)

Net Income Summary of Silver Spike Investment Corp.

  • Silver Spike Investment Corp.'s latest annual net income in 2023 was 7.34 Million USD , up 329.72% from previous year.
  • Silver Spike Investment Corp.'s latest quarterly net income in 2024 Q1 was - USD , down -100.0% from previous quarter.
  • Silver Spike Investment Corp. reported an annual net income of 1.7 Million USD in 2022, up 403.2% from previous year.
  • Silver Spike Investment Corp. reported an annual net income of -563.36 Thousand USD in 2021, up 41.21% from previous year.
  • Silver Spike Investment Corp. reported a quarterly net income of 2.35 Million USD for 2023 Q1, up 104.61% from previous quarter.
  • Silver Spike Investment Corp. reported a quarterly net income of 2.49 Million USD for 2023 Q4, up 96.07% from previous quarter.

Annual Net Income Chart of Silver Spike Investment Corp. (2023 - 2020)

Historical Annual Net Income of Silver Spike Investment Corp. (2023 - 2020)

Year Net Income Net Income Growth
2023 7.34 Million USD 329.72%
2022 1.7 Million USD 403.2%
2021 -563.36 Thousand USD 41.21%
2020 -958.29 Thousand USD 0.0%

Peer Net Income Comparison of Silver Spike Investment Corp.

Name Net Income Net Income Difference
ANI Pharmaceuticals, Inc. 18.77 Million USD 60.913%
Aquestive Therapeutics, Inc. -7.87 Million USD 193.267%
Collegium Pharmaceutical, Inc. 48.15 Million USD 84.757%
Cosmos Health Inc. -18.54 Million USD 139.585%
Cyclo Therapeutics, Inc. -20.05 Million USD 136.596%
Esperion Therapeutics, Inc. -209.24 Million USD 103.508%
Cronos Group Inc. -73.96 Million USD 109.924%
Incannex Healthcare Limited -18.45 Million USD 139.764%
Kala Pharmaceuticals, Inc. -42.19 Million USD 117.394%
Lifecore Biomedical, Inc. 12.01 Million USD 38.899%
Regencell Bioscience Holdings Limited -4.3 Million USD 270.627%
Sunshine Biopharma, Inc. -4.5 Million USD 262.895%
Sunshine Biopharma, Inc. -4.5 Million USD 262.895%
SCYNEXIS, Inc. 67.04 Million USD 89.051%
Safety Shot Inc -15.08 Million USD 148.665%
Theratechnologies Inc. -23.95 Million USD 130.639%
Alpha Teknova, Inc. -36.78 Million USD 119.957%
Universe Pharmaceuticals INC -6.16 Million USD 219.098%
Pacira BioSciences, Inc. 41.95 Million USD 82.505%
Sonoma Pharmaceuticals, Inc. -4.83 Million USD 251.812%
Dynavax Technologies Corporation -6.38 Million USD 214.887%
Ironwood Pharmaceuticals, Inc. -1 Billion USD 100.732%
Radius Health, Inc. -25.79 Million USD 128.46%
China SXT Pharmaceuticals, Inc. -3.09 Million USD 336.89%
Alvotech -551.73 Million USD 101.33%
Intra-Cellular Therapies, Inc. -139.67 Million USD 105.255%
SIGA Technologies, Inc. 68.06 Million USD 89.217%
Shineco, Inc. -22.44 Million USD 132.697%
Journey Medical Corporation -3.85 Million USD 290.504%
Petros Pharmaceuticals, Inc. -8.16 Million USD 189.917%
Embecta Corp. 70.4 Million USD 89.574%
Harrow Health, Inc. -24.41 Million USD 130.069%
Procaps Group, S.A. 42.54 Million USD 82.745%
Biofrontera Inc. -20.13 Million USD 136.462%
DURECT Corporation -27.62 Million USD 126.571%
PainReform Ltd. -9.34 Million USD 178.554%
Supernus Pharmaceuticals, Inc. 1.31 Million USD -457.759%
OptiNose, Inc. -35.48 Million USD 120.686%
RedHill Biopharma Ltd. 23.91 Million USD 69.309%
Organogenesis Holdings Inc. 4.94 Million USD -48.435%
Cumberland Pharmaceuticals Inc. -6.27 Million USD 216.893%
ProPhase Labs, Inc. -16.78 Million USD 143.738%
Phibro Animal Health Corporation 2.41 Million USD -203.812%
Procaps Group S.A. 42.54 Million USD 82.745%
TherapeuticsMD, Inc. -10.27 Million USD 171.416%
Viatris Inc. 54.7 Million USD 86.581%
Rockwell Medical, Inc. -8.43 Million USD 186.978%
Aytu BioPharma, Inc. -15.84 Million USD 146.327%
Tilray Brands, Inc. -244.98 Million USD 102.996%
PetIQ, Inc. 2.13 Million USD -244.444%
Talphera, Inc. -18.39 Million USD 139.898%
Neurocrine Biosciences, Inc. 249.7 Million USD 97.06%
Alimera Sciences, Inc. -20.13 Million USD 136.46%
Assertio Holdings, Inc. -331.94 Million USD 102.211%
Shuttle Pharmaceuticals Holdings, Inc. -6.59 Million USD 211.337%
Avadel Pharmaceuticals plc -160.27 Million USD 104.58%
Hempacco Co., Inc. -13.12 Million USD 155.92%
Alvotech -551.73 Million USD 101.33%
Lantheus Holdings, Inc. 326.66 Million USD 97.753%
Kamada Ltd. 8.28 Million USD 11.394%
Currenc Group, Inc. -15.3 Million USD 147.954%
Indivior PLC 2 Million USD -267.005%
Evoke Pharma, Inc. -7.79 Million USD 194.197%
Flora Growth Corp. -57.03 Million USD 112.869%
Cyclo Therapeutics, Inc. -20.05 Million USD 136.596%
Evolus, Inc. -61.68 Million USD 111.899%
HUTCHMED (China) Limited 100.78 Million USD 92.717%
Amphastar Pharmaceuticals, Inc. 137.54 Million USD 94.663%
Akanda Corp. -32.27 Million USD 122.742%